Myostatin: A Powerful Biomarker for Sarcopenia and Frailty?

Gerontology. 2019;65(4):383-384. doi: 10.1159/000495839. Epub 2019 Mar 14.

Authors

Michaël R Laurent¹, Jolan Dupont², Marian Dejaeger², Evelien Gielen²

Affiliations

¹ Gerontology and Geriatrics Section, Department of Chronic Diseases, Metabolism and Ageing (CHROMETA), KU Leuven, University Hospitals, Leuven, Belgium, michael.laurent@uzleuven.be.
² Gerontology and Geriatrics Section, Department of Chronic Diseases, Metabolism and Ageing (CHROMETA), KU Leuven, University Hospitals, Leuven, Belgium.

PMID: 30870838
DOI: 10.1159/000495839

No abstract available

Publication types

Letter
Comment

MeSH terms

Biomarkers
Exercise Therapy
Frailty*
Humans
Myostatin
Nursing Homes
Sarcopenia*

Substances

Biomarkers
Myostatin